Giardia assemblage A: human genotype in muskoxen in the Canadian Arctic.Implementing and evaluating a program to facilitate chronic disease prevention and screening in primary care: a mixed methods program evaluationEconomic analyses of rubella and rubella vaccines: a global review.Developing clinical decision tools to implement chronic disease prevention and screening in primary care: the BETTER 2 program (building on existing tools to improve chronic disease prevention and screening in primary care).A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents.Obesity studies in the circumpolar Inuit: a scoping review.Examining DNA fingerprinting as an epidemiology tool in the tuberculosis program in the Northwest Territories, Canada.The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern CanadaHospital admission rates for lower respiratory tract infections in infants in the Northwest Territories and the Kitikmeot region of Nunavut between 2000 and 2004.Assessing determinants of maternal blood concentrations for persistent organic pollutants and metals in the eastern and western Canadian Arctic.Molecular typing of Treponema pallidum strains in western Canada: predominance of 14d subtypes.Comparing plasma concentrations of persistent organic pollutants and metals in primiparous women from northern and southern Canada.Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tHaemophilus Disease in Alaskan and Canadian ChildrenFactors associated with human papillomavirus infection among women in the Northwest TerritoriesWhole genome sequencing to study the phylogenetic structure of serotype a Haemophilus influenzae recovered from patients in Canada
P50
Q33371072-DB2D3F09-6E72-4D54-8967-4570D1D3A1E7Q34325970-345CBBC7-E0FC-4D1C-B7B9-E7820DEED22EQ34697580-D0BCE6C2-3322-4576-9F12-6C6FF63FA992Q35913484-584280F7-F342-4EC4-8374-46105CC92948Q36171118-B76DED97-B5D9-4E90-B78D-C2D5FF98AB01Q36349359-3D192169-5035-4DF7-B8DB-F4EF037E9044Q36832155-27F74E42-6075-40BA-B55F-57848430B02FQ37056980-1CA11437-56DD-4ABF-B65E-7C47D075089AQ37333767-21DA13EE-F30E-41B4-A084-718D96AE2F79Q40949137-35496DAC-7A64-4D63-BC30-F2AE831CDDD1Q43030533-B8F55790-0728-4046-82DF-E66F8A13AECAQ44148299-4F92A8B4-ED86-41B4-B69F-CD19455710C3Q45619007-AB2BE382-B577-4BA4-92BB-6B2658F66FD5Q58438773-E91BF138-CA24-48F8-874F-1CF4C3778D05Q86657082-C671B394-59C5-4870-AD97-9299EA218F19Q90987095-76636FEF-0AEE-4841-B56F-93D1C4214E07
P50
description
Canadian doctor, Chief Public Health Officer for Northwest Territories
@en
name
Kami Kandola
@en
Kami Kandola
@nl
type
label
Kami Kandola
@en
Kami Kandola
@nl
altLabel
K Kandola
@en
prefLabel
Kami Kandola
@en
Kami Kandola
@nl